Howard Capital Management Inc. Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Howard Capital Management Inc. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,681 shares of the company’s stock after purchasing an additional 313 shares during the period. Howard Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $835,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. LGT Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 251 shares during the period. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies during the third quarter worth $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the third quarter valued at $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the third quarter valued at $31,000. Finally, Continuum Advisory LLC lifted its holdings in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 1.1 %

Shares of NASDAQ GEHC opened at $91.09 on Monday. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The firm has a market cap of $41.66 billion, a PE ratio of 21.04, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The business has a fifty day simple moving average of $85.05 and a two-hundred day simple moving average of $85.90. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analysts Set New Price Targets

GEHC has been the topic of several analyst reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.